HIV Infections study: TM HIV vs TM HL
Official title Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
ClinicalTrials.gov ID: NCT06088277
What this study is testing
- What it's testing
- This is a 3-year study to test how well it works of a text message-based intervention program.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Give informed consent and document consent via a signed and dated informed consent form in REDCap
- Willing to comply with all study procedures and be available for the duration of the study
- Be able to read either in English or Spanish
- Be a dental clinic patient of record at one of our participating community health centers
- Has at least one risk factor for HIV defined as self-report of at least one of the following: Men who have sex with men
You likely can't join if
- Self-report of having HIV infection
- Participating in another HIV study or another text message study
- A woman who reports having sex exclusively with women
- Does not have a mobile phone or other device which can receive text messages from Agile Health
- Does not have unlimited texting on their mobile plan
- Has not used any type of text messaging at least once in the past month
See the full eligibility criteria
- Give informed consent and document consent via a signed and dated informed consent form in REDCap
- Willing to comply with all study procedures and be available for the duration of the study
- Be able to read either in English or Spanish
- Be a dental clinic patient of record at one of our participating community health centers
- Has at least one risk factor for HIV defined as self-report of at least one of the following: Men who have sex with men; multiple sex partners, or intravenous drug use
- Self-report of having HIV infection
- Participating in another HIV study or another text message study
- A woman who reports having sex exclusively with women
- Does not have a mobile phone or other device which can receive text messages from Agile Health
- Does not have unlimited texting on their mobile plan
- Has not used any type of text messaging at least once in the past month
- Single item literacy screening score of 2 or below.
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.